Share

April 06, 2015; 84 (14 Supplement) April 21, 2015

Effect of Fingolimod on No Evidence of Disease Activity (NEDA-4) and Safety in Young Adult Patients with Relapsing-Remitting Multiple Sclerosis (P3.277)

Angelo Ghezzi, Goeril Karlsson, Dieter Haering, Jutta Gärtner, Tanuja Chitnis, Daniela Pohl, Norman Putzki
First published April 8, 2015,
Citation
Permissions

Make Comment

See Comments

Downloads
0

Share

Article Information

vol. 84 no. 14 Supplement P3.277
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published April 8, 2015.
Copyright & Usage: 
Copyright © 2015 by AAN Enterprises, Inc.

Author Disclosures

    1. Angelo Ghezzi1,
    2. Goeril Karlsson3,
    3. Dieter Haering3,
    4. Jutta Gärtner5,
    5. Tanuja Chitnis4,
    6. Daniela Pohl2 and
    7. Norman Putzki3
  1. Angelo Ghezzi1,
  2. Goeril Karlsson3,
  3. Dieter Haering3,
  4. Jutta Gärtner5,
  5. Tanuja Chitnis4,
  6. Daniela Pohl2 and
  7. Norman Putzki3
  1. 1Centro Studi Sclerosi Multipla Gallarate Italy
  2. 2Children’s Hospital of Eastern Ontario Ottawa ON Canada
  3. 3Novartis Pharma AG Basel Switzerland
  4. 4Partners Pediatric Multiple Sclerosis Centre Brookline MA United States
  5. 5Dept. of Pediatrics and Adolescent Medicine University Medicine Göttingen Germany

Article usage

Article usage: April 2015 to May 2022

AbstractFullPdfSource
Apr 20154400Highwire
May 201518100Highwire
Jun 201519500Highwire
Jul 201518800Highwire
Aug 201513100Highwire
Sep 201511300Highwire
Oct 201515500Highwire
Nov 201515300Highwire
Dec 20154600Highwire
Jan 20163700Highwire
Feb 20163800Highwire
Mar 20163800Highwire
Apr 20166000Highwire
May 20162100Highwire
Jun 20166400Highwire
Jul 20161800Highwire
Aug 20162800Highwire
Sep 20161500Highwire
Oct 20161500Highwire
Nov 20161900Highwire
Dec 20161500Highwire
Jan 20171700Highwire
Feb 20172800Highwire
Mar 20171500Highwire
Apr 2017900Highwire
May 20171200Highwire
Jun 20171200Highwire
Jul 20171400Highwire
Aug 2017400Highwire
Sep 2017300Highwire
Oct 2017200Highwire
Nov 2017500Highwire
Dec 2017400Highwire
Jan 2018900Highwire
Feb 2018500Highwire
Mar 2018300Highwire
Apr 2018900Highwire
May 20182000Highwire
Jun 20181000Highwire
Jul 20181000Highwire
Aug 2018400Highwire
Sep 20181200Highwire
Oct 2018900Highwire
Nov 20181100Highwire
Dec 20181100Highwire
Jan 2019200Highwire
Feb 2019500Highwire
Mar 2019200Highwire
Apr 2019500Highwire
May 20191200Highwire
Jun 2019400Highwire
Jul 20193100Highwire
Aug 2019800Highwire
Sep 2019800Highwire
Oct 2019600Highwire
Nov 2019300Highwire
Dec 2019300Highwire
Jan 2020800Highwire
Feb 2020400Highwire
Mar 2020400Highwire
Apr 2020300Highwire
May 2020600Highwire
Jun 2020500Highwire
Jul 2020600Highwire
Aug 2020500Highwire
Sep 2020500Highwire
Oct 2020800Highwire
Nov 2020600Highwire
Dec 2020300Highwire
Jan 2021400Highwire
Feb 2021300Highwire
Mar 2021800Highwire
Apr 2021400Highwire
May 2021500Highwire
Jun 2021800Highwire
Jul 2021900Highwire
Aug 2021100Highwire
Sep 2021500Highwire
Oct 2021900Highwire
Nov 2021900Highwire
Dec 2021400Highwire
Jan 2022500Highwire
Feb 2022500Highwire
Mar 2022300Highwire
Apr 2022500Highwire
May 2022600Highwire

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Alert Me